Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Walley

Showing results (41-50 of 152) with videos related to

Pageof 16
Sort By:
Clinical Pharmacology and Therapeutics|June 20, 2008
Pharmacoeconomics comes of age?T Walley, A Breckenridge
BMJ (Clinical Research Ed.)|January 18, 1992
FHSA medical advisers: friends or foes?T Walley, J Bligh
British Journal of Clinical Pharmacology|April 1, 1997
Pharmacoeconomics: basic concepts and terminologyT Walley, A Haycox
Pharmacoepidemiology and Drug Safety|November 26, 2008
Average daily quantities: a tool for measuring prescribing volume in EnglandT Walley, D Roberts
Pharmacoeconomics|January 8, 1993
Health economics in primary care in the UK: containment of drug costsT Walley, R T Edwards
Pharmacoeconomics|December 12, 2001
Economic evaluations during early (phase II) drug development: a role for clinical trial simulations?D A Hughes, T Walley
Clinical Performance and Quality Health Care|February 24, 2001
Donepezil and Alzheimer's dementiaA Earl-Slater, T Walley
Pharmacoeconomics|January 8, 1994
Is there a need for an independent centre for pharmacoeconomics in the UK?T Walley, R T Edwards
Lancet (London, England)|October 21, 1995
Bayer promotional publications misleading about effect of ciprofloxacin on hospital admissionsS B Barton, T Walley
Journal of the Royal College of Physicians of London|July 1, 1990
The clinical and scientific basis of drug toxicity. A report of a conferenceR R Shah, T Walley
Pageof 16

Showing results (41-50 of 152) with videos related to

Sort By:
Pageof 16
Clinical Pharmacology and Therapeutics|June 20, 2008
Pharmacoeconomics comes of age?T Walley, A Breckenridge
BMJ (Clinical Research Ed.)|January 18, 1992
FHSA medical advisers: friends or foes?T Walley, J Bligh
British Journal of Clinical Pharmacology|April 1, 1997
Pharmacoeconomics: basic concepts and terminologyT Walley, A Haycox
Pharmacoepidemiology and Drug Safety|November 26, 2008
Average daily quantities: a tool for measuring prescribing volume in EnglandT Walley, D Roberts
Pharmacoeconomics|January 8, 1993
Health economics in primary care in the UK: containment of drug costsT Walley, R T Edwards
Pharmacoeconomics|December 12, 2001
Economic evaluations during early (phase II) drug development: a role for clinical trial simulations?D A Hughes, T Walley
Clinical Performance and Quality Health Care|February 24, 2001
Donepezil and Alzheimer's dementiaA Earl-Slater, T Walley
Pharmacoeconomics|January 8, 1994
Is there a need for an independent centre for pharmacoeconomics in the UK?T Walley, R T Edwards
Lancet (London, England)|October 21, 1995
Bayer promotional publications misleading about effect of ciprofloxacin on hospital admissionsS B Barton, T Walley
Journal of the Royal College of Physicians of London|July 1, 1990
The clinical and scientific basis of drug toxicity. A report of a conferenceR R Shah, T Walley
Pageof 16